United Services Automobile Association Esperion Therapeutics, Inc. Transaction History

United Services Automobile Association

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 13, 2019	SELL	$40.11 - $53.57 $1.6 Million - $2.14 Million	-39,928 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$36.99 - $59.11 $45,460 - $72,646	-1,229 Reduced 2.99%	39,928 $1.84 Million
Q3 2018 Nov 13, 2018	SELL	$40.74 - $51.41 $16,458 - $20,769	-404 Reduced 0.97%	41,157 $1.83 Million
Q2 2018 Sep 27, 2018	BUY	$36.2 - $76.4 $1.21 Million - $2.56 Million	33,501 Added 415.65%	41,561 $1.63 Million
Q2 2018 Aug 10, 2018	BUY	$36.2 - $76.4 $169,054 - $356,788	4,670 Added 137.76%	8,060 $715,000
Q1 2018 May 14, 2018	BUY	$65.94 - $80.76 $223,536 - $273,776	3,390 New	3,390 $245,000

206

128M

1.67M

930K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $153M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

Stay updated on United Services Automobile Association with notifications on news.